In Recognition of Lung Cancer Awareness Month

Best Practices in Lung Cancer – November 2017 Vol 8 —November 15, 2017
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

Dear Navigators,

The principles of navigation began in the discipline of breast cancer. After observing the tremendous success of removing barriers to care as an effective method to improve clinical outcome and patient satisfaction, navigation tactics have been incorporated into many oncology disciplines. In this Special Edition, we direct our attention to lung cancer and the positive impact navigators have had in this disease state.

Lung cancer is a field in which great strides have been made over the past decade. From smoking cessation programs to the introduction of immunotherapy to the development and implementation of lung nodule screening, patients living with lung cancer have more treatment options and lifestyle-enhancing services available to them than ever before.

In this issue, we present an interview with Wendy Brooks, RN, ONN-CG(T), a thoracic nurse navigator at the HCA Midwest Research Medical Center, about her typical, or not so typical, day as a navigator. We are pleased to present an article by Amy M. Norton, RN, MSN, ONN-CG(T), and colleagues entitled “Lung Cancer. Now What? Plans and How We ‘Navigate’ Them.” We also bring you news in lung cancer from the European Society for Medical Oncology 2017 Congress.

It is our hope that this issue is a valuable resource to the nurse and patient navigators who work tirelessly to help their patients living with lung cancer. Thank you for all you do for your patients and for your valued and loyal readership.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+

University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
Promising Response with Sotorasib in a Patient with KRAS G12C–Mutated Lung Cancer and Brain Metastases
Web Exclusives
Sotorasib in a patient with KRAS G12C–mutated lung cancer and brain metastases resolved or shrank brain lesions and improved mental status.
Broad and Rapid Genomic Profiling Recommended for Clinical Management of Patients with NSCLC
Web Exclusives
In patients with non–small-cell lung cancer, broad and rapid genomic profiling are recommended for use at all stages of clinical management to improve patient outcomes.
ICI Discontinuation Appropriate after Grade ≥2 Immune-Related AEs in Patients with Stage IV NSCLC
Web Exclusives
Study determines that permanently discontinuing immune checkpoint inhibitors after grade ≥2 immune-related adverse events is an appropriate response for patients with stage IV non–small-cell lung cancer.
Last modified: November 15, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country